tiprankstipranks
Advertisement
Advertisement

IRD Stock Latest News

Opus Genetics management to meet with B. Riley
The FlyOpus Genetics management to meet with B. Riley
3d ago
IRD
Opus Genetics Adopts Change-in-Control Executive Bonus Agreements
PremiumCompany Announcements
Opus Genetics Adopts Change-in-Control Executive Bonus Agreements
10d ago
8K
IRD
Opus Genetics Secures Major Non-Dilutive Funding Facility
PremiumCompany Announcements
Opus Genetics Secures Major Non-Dilutive Funding Facility
10d ago
8K
IRD
3 Best Stocks to Buy Today, 3/30/2026, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Today, 3/30/2026, According to Top Analysts
18d ago
IRD
GENI
Opus Genetics initiated with an Overweight at Cantor Fitzgerald
PremiumThe Fly
Opus Genetics initiated with an Overweight at Cantor Fitzgerald
18d ago
IRD
Opus Genetics initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyOpus Genetics initiated with an Overweight at Cantor Fitzgerald
18d ago
IRD
Oppenheimer bullish on Opus Genetics, initiates with an Outperform
Premium
The Fly
Oppenheimer bullish on Opus Genetics, initiates with an Outperform
1M ago
IRD
Opus Genetics initiated with an Outperform at Oppenheimer
Premium
The Fly
Opus Genetics initiated with an Outperform at Oppenheimer
1M ago
IRD
Opus Genetics files to sell 7.37M shares of common stock for holders
PremiumThe Fly
Opus Genetics files to sell 7.37M shares of common stock for holders
1M ago
IRD
Viatris-Backed Nyxol Trial Completes Phase 3, Setting Up a Key Night-Vision Catalyst
PremiumCompany Announcements
Viatris-Backed Nyxol Trial Completes Phase 3, Setting Up a Key Night-Vision Catalyst
1M ago
IRD
VTRS
Ocuphire’s Nyxol Presbyopia Trial Nears Data: What Investors Should Watch
PremiumCompany Announcements
Ocuphire’s Nyxol Presbyopia Trial Nears Data: What Investors Should Watch
1M ago
IRD
Opus Genetics price target raised to $10 from $8 at Wedbush
PremiumThe Fly
Opus Genetics price target raised to $10 from $8 at Wedbush
1M ago
IRD
Buy Rating on Opus Genetics Driven by Advancing Gene Therapy Pipeline, Near‑Term Clinical Catalysts, and Solid Cash Runway
PremiumRatingsBuy Rating on Opus Genetics Driven by Advancing Gene Therapy Pipeline, Near‑Term Clinical Catalysts, and Solid Cash Runway
1M ago
IRD
Opus Genetics: Advancing Late-Stage Gene Therapy Pipeline and 2026 Data Catalysts Support Buy Rating and $10 Target
Premium
Ratings
Opus Genetics: Advancing Late-Stage Gene Therapy Pipeline and 2026 Data Catalysts Support Buy Rating and $10 Target
1M ago
IRD
Opus Genetics reports FY25 EPS (80c) vs ($2.15) last year
Premium
The Fly
Opus Genetics reports FY25 EPS (80c) vs ($2.15) last year
1M ago
IRD
Opus Genetics price target raised to $12 from $7 at BTIG
PremiumThe Fly
Opus Genetics price target raised to $12 from $7 at BTIG
2M ago
IRD
Opus Genetics announces initial data from Phase 1/2 study of OPGx-BEST1
PremiumThe Fly
Opus Genetics announces initial data from Phase 1/2 study of OPGx-BEST1
2M ago
IRD
Buy Rating on IRD Driven by Low-Risk Presbyopia Launch and High-Potential BEST1 Gene Therapy Pipeline
PremiumRatings
Buy Rating on IRD Driven by Low-Risk Presbyopia Launch and High-Potential BEST1 Gene Therapy Pipeline
2M ago
IRD
Opus Genetics says FDA accepts sNDA for phentolamine ophthalmic solution 0.75%
PremiumThe Fly
Opus Genetics says FDA accepts sNDA for phentolamine ophthalmic solution 0.75%
2M ago
IRD
Opus Genetics Closes $25 Million Series B Financing
PremiumCompany AnnouncementsOpus Genetics Closes $25 Million Series B Financing
2M ago
8K
IRD
Opus Genetics prices 7.37M Preferred Stock at $3.39 in private placement
Premium
The Fly
Opus Genetics prices 7.37M Preferred Stock at $3.39 in private placement
2M ago
IRD
Opus Genetics initiated with an Outperform at LifeSci Capital
Premium
The Fly
Opus Genetics initiated with an Outperform at LifeSci Capital
2M ago
IRD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >